Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects

Journal of Neurochemistry

Volumn 77, Issue 3, 2001, Pages 916-928

  Dwivedi, Y ^a   Rizavi, H S ^a   Roberts, R C ^b   Conley, R C ^b   Tamminga, C A ^b   Pandey, G N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Depression; ERK1 2; Human post mortem brain; MKP2; p42 44 MAP kinases; Suicide

Indexed keywords

MAP KINASE PHOSPHATASE 2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CADAVER; CONTROLLED STUDY; DEPRESSION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUICIDE;

ADULT; AGED; BRAIN; CELL MEMBRANE; CELL NUCLEUS; CYTOSOL; DEPRESSION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PREFRONTAL CORTEX; PROTEIN-TYROSINE-PHOSPHATASE; RNA, MESSENGER; SUICIDE;

EID: 0035020808     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00300.x     Document Type: Article

References (57)

1. Abe M. K., Kuo W. L., Hershenson M. B. and Rosner M. R. (1999) Extracellular signal-regulated kinase 7 (ERK7), a novel ERK with a C-terminal domain that regulates its activity, its cellular localization, and cell growth. Mol. Cell. Biol. 19, 1301-1312.
2. Alessi D. R., Gomez N., Moorhead G., Lewis T., Keyse S. M. and Cohen P. (1995) Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr. Biol. 5, 283-295.
3. Bonni A., Brunet A., West A. E., Datta S. R., Takasu M. A. and Greenberg M. E. (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286, 1358-1362.
4. Boulton T. G. and Cobb M. H. (1991) Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. Cell Regul. 2, 357-371.
5. Cavanaugh J E., Ham J., Hetman M., Poser S., Yan C. and Xia Z. (2001) Differential regulation of mitogen-activated protein kinases ERK1/2, ERKS by neurotrophins neuronal activity, cAMP in neurons. J. Neurosci. 15, 434-443.
6. Charest D. L., Mordret G., Harder K. W., Jirik F. and Pelech S. L. (1993) Molecular cloning, expression, and characterization of the human mitogen-activated protein kinase p44erk1. Mol. Cell. Biol. 13, 4679-4690.
7. Chen R. H., Sarnecki C. and Blenis J. (1992) Nuclear localization and regulation of erk-and rsk-encoded protein kinases Mol. Cell Biol. 12, 915-927.
8. Cobb M. H. (1999) MAP kinase pathways. Prog. Biophys. Mol. Biol. 71, 479-500.
9. Cowen D. S., Sowers R. S. and Manning D. R. (1996) Activation of a mitogen-activated protein kinase (ERK2) by the 5-hydroxytryptamine 1A receptor is sensitive not only to inhibitors of phosphatidylinositol 3-kinase, but to an inhibitor of phosphatidylcholine hydrolysis. J. Biol. Chem 271, 22297-22300.
10. Davis R. J. (1993) The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268, 14553-14556.
11. 1 isozyme in rat brain. J. Neurochem. 73, 780-790.
12. 3H]cyclic AMP binding sites and PKA activity in the prefrontal cortex of suicide subjects. Soc. Neurosc. Abstract 25, 2097.
13. Garrington T. P. and Johnson G. L. (1999) Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11, 211-218.
14. Gomez N. and Cohen P. (1991) Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 353, 170-173.
15. Gopalbhai K. and Meloche S. (1998) Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins. J. Cell Physiol. 174, 35-47.
16. Grewal S. S., York R. D. and Stork P. J. (1999) Extracellular-signal-regulated kinase signalling in neurons. Curr. Opin. Neurobiol. 9, 544-553.
17. Gross-Isseroff R., Biegon A., Voet H. and Weizman A. (1998) The suicide brain: a review of postmortem receptor/transporter binding studies. Neurosci. Biobehav. 22, 653-661.
18. Guan K. L. (1994) The mitogen activated protein kinase signal transduction pathway: from the cell surface to the nucleus. Cell Signal 6, 581-589.
19. Gutkind J. S. (1998) The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades. J. Biol. Chem. 273, 1839-1842.
20. Haycock J. W., Ahn N. G., Cobb M. H. and Krebs E. G. (1992) ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc. Natl. Acad. Sci. USA 89, 2365-2369.
21. Hetman M., Kanning K., Cavanaugh J. E. and Xia Z. (1999) Neuroprotection by brain-derived neurotrophic factor is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase. J. Biol. Chem. 274, 22569-22580.
22. Khohklatchev A. V., Canagarajah B., Wilsbacher J., Robinson M., Atkinson M., Goldsmith E. and Cobb M. H. (1998) Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell 93, 605-615.
23. Kolkova K., Novitskaya V., Pedersen N., Berezin V. and Bock E. (2000) Neural cell adhesion molecule-stimulated neurite outgrowth depends on activation of protein kinase C and the Ras-mitogen-activated protein kinase pathway. J. Neurosci. 20, 2238-2246.
24. Kurino M., Fukunaga K., Ushio Y. and Miyamoto E. (1995) Activation of mitogen-activated protein kinase in cultured rat hippocampal neurons by stimulation of glutamate receptors. J. Neurochem. 65, 1282-1289.
25. Kyosseva S. V., Elbein A. D., Griffin W. S., Mrak R. E., Lyon M. and Karson C. N. (1999) Mitogen-activated protein kinases in schizophrenia. Biol. Psychiatry 46, 689-696.
26. 2B receptor. J. Biol. Chem. 271, 3141-3147.
27. Lewis T. S., Shapiro P. S. and Ahn N. G. (1998) Signal transduction through MAP kinase cascades. Adv. Cancer Res. 74, 49-139.
28. Lin L. L., Wartmann M., Lin A. Y., Knopf J. L., Seth A. and Davis R. J. (1993) cPLA2 is phosphorylated and activated by MAP kinase. Cell 72, 269-278.
29. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with folin phenol reagent. J. Biol. Chem. 193, 265-275.
30. McDuffie J. E., Motley E. D., Limbird L. E. and Maleque M. A. (2000) 5-hydroxytryptamine stimulates phosphorylation of p44/p42 mitogen-activated protein kinase activation in bovine aortic endothelial cell cultures. J. Cardiovasc Pharmacol 35, 398-402.
31. Marais R., Wynne J. and Treisman R. (1993) The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73, 381-393.
32. Miyata Y., Akashi M. and Nishida E. (1999) Molecular cloning and characterization of a novel member of the MAP kinase superfamily. Genes Cells 4, 299-309.
33. Nibuya M., Morinobu S. and Duman R. S. (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J. Neurosci. 15, 7539-7547.
34. Ongur D., Drevets W. C. and Price J. L. (1998) Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. USA 95, 13290-13295.
35. Ortiz J., Harris H. W., Guitart X., Terwilliger R. Z., Haycock J. W. and Nestler E. J. (1995) Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J. Neurosci. 15, 1285-1297.
36. Owaki H., Makar R., Boulton T. G., Cobb M. H. and Geppert T. D. (1992) Extracellular signal-regulated kinases in T cells: characterization of human ERK1 and ERK2 cDNAs. Biochem. Biophys. Res. Commun. 182, 1416-1422.
37. Pandey G. N., Dwivedi Y., Pandey S. C., Conley R. R., Roberts R. C. and Tamminga C. A. (1997) Protein kinase C in the postmortem brain of teenage suicide victims. Neurosci. Lett. 228, 111-114.
38. 1 protein in the prefrontal cortex of teenage suicide subjects. Am. J. Psychiatry 156, 1895-1901.
39. Pulverer B. J., Kyriakis J. M., Avruch J., Nikolakaki E. and Woodgett J. R. (1991) Phosphorylation of c-jun mediated by MAP kinases. Nature 353, 670-674.
40. 3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. J. Neurochem. 68, 297-304.
41. Rajkowska G. (2000) Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol. Psychiatry 48, 766-777.
42. Rajkowska G., Miguel-Hidalgo J. J., Wei J., Dilley G., Pittman S. D., Meltzer H. Y., Overholser J. C., Roth B. L. and Stockmeier C. A. (1999) Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol. Psychiatry. 45, 1085-1098.
43. Reiach J. S., Li P. P., Warsh J. J., Kish S. J. and Young L. T. (1999) Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims. J. Affect. Disord. 56, 141-151.
44. Reszka A. A., Seger R., Diltz C. D., Krebs E. G. and Fischer E. H. (1995) Association of mitogen-activated protein kinase with the microtubule cytoskeleton. Proc. Natl. Acad. Sci. USA 92, 8881-8885.
45. Robertson E. D., English J. D., Adams J. P., Selcher J. C., Kondratick C. and Sweatt J. D. (1999) The mitogen-activated protein kinase cascade couples PKA and PKC to cAMP response element binding protein phosphorylation in area CA1 of hippocampus. J. Neurosci. 19, 4337-4348.
46. Runden E., Seglen P. O., Huag F.-M., Ottersen O. P., Wieloch T., Shamloo M. and Laake J. H. (1998) Regional selective neuronal degeneration after protein phosphatase inhibition in hippocampal slice culture: evidence for a MAP kinase-dependent mechanism. J. Neurosci. 18, 7296-7305.
47. Salzman S., Endicott J., Clayton P. and Winokur G. (1983) Diagnostic Evaluation After Death (DEAD). National Institute of Mental Health, Neuroscience Research Branch, Rockville, MD.
48. Segal R. and Greenberg M. (1996) Intracellular signaling pathways activated by neurotrophic factors. Annu. Rev. Neurosci. 19, 463-489.
49. Seger R. and Krebs E. G. (1995) The MAPK signaling cascade. FASEB J. 9, 726-735.
50. Sheline Y. I., Wang P. W., Gado M. H., Csernansky J. G. and Vannier M. W. (1996) Hippocampal atrophy in recurrent major depression. Proc. Natl Acad. Sci. USA 93, 3908-3913.
51. Smith M. A., Makino S., Kvetnansky R. and Post R. M. (1995) Effects of stress on neurotrophic factor expression in the rat brain. Ann. NY Acad. Sci. 771, 234-239.
52. Sturgill T. W. and Wu J. (1991) Recent progress in characterization of protein kinase cascades for phosphorylation of ribosomal protein Sb. Biochim. Biophys Acta 1092, 350-357.
53. Sun H., Charles C. H., Lau L. F. and Tonks N. K. (1993) MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75, 487-493.
54. Watts S. W. (1996) Serotonin activates the mitogen-activated protein kinase pathway in vascular smooth muscle: use of the mitogen-activated protein kinase inhibitor PD 098059. J. Pharmacol. Exp. Ther. 279, 1541-1550.
55. Widmann C., Gibson S., Jarpe M. D. and Johnson G. L. (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79, 143-180.
56. Xia Z., Dickens M., Raingeaud J., Davis R. J. and Greenberg M. E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326-1331.
57. 2-terminal kinases (JNKs) in vitro and in the CNS in vivo. J. Neurochem. (in press).